Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Carboplatin × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Gynecologic 1

Conditions

Ovarian Neoplasms 323 Fallopian Tube Neoplasms 159 Carcinoma, Ovarian Epithelial 114 Endometrial Neoplasms 76 Uterine Cervical Neoplasms 72 Neoplasms 28 Carcinoma, Non-Small-Cell Lung 23 Breast Neoplasms 23 Brenner Tumor 21 Recurrence 19 Testicular Neoplasms 17 Peritoneal Neoplasms 17 Stomach Neoplasms 14 Pancreatic Neoplasms 11 Neoplasm Metastasis 11 Urinary Bladder Neoplasms 10 Triple Negative Breast Neoplasms 10 Testicular Germ Cell Tumor 10 Sarcoma 10 Lung Neoplasms 10 Colorectal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Teratoma 8 Ovarian Germ Cell Cancer 8 Neuroectodermal Tumors, Primitive, Peripheral 8 Central Nervous System Neoplasms 8 Uterine Neoplasms 7 Melanoma 7 Esophageal Neoplasms 7

Interventions

Neoadjuvant Therapy 1 Docetaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡